Atreca Inc - Ordinary Shares - Class A

NASDAQ:BCEL  
2.86
-0.85 (-22.91%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Atreca Inc - Ordinary Shares - Class A Stock, NASDAQ:BCEL

835 Industrial Road, Suite 400, San Carlos, California 94070
United States of America
Phone: +1.650.595.2595
Number of Employees: 130

Description

Atreca, Inc. is a biopharmaceutical company. It develops novel therapeutics and immunotherapies based on a deep understanding of the human immune response. Its technology leverages next-generation sequencing to identify the set of functional antibodies produced in patients during an immune response. The company was founded by Robert Axtell, Guy Cavet, Jeremy Sokolove, Tito A. Serafini, Paulette A. Dillon, Daniel Emerling, Wayne Volkmuth, Jonathan Woo, Yann Chong Tan, William H. Robinson and Lawrence J. Steinman on June 11, 2010 and is headquartered in San Carlos, CA.